HEADER PROTEIN BINDING/INHIBITOR 10-JAN-18 6C3L TITLE CRYSTAL STRUCTURE OF BCL6 BTB DOMAIN WITH COMPOUND 15F COMPND MOL_ID: 1; COMPND 2 MOLECULE: B-CELL LYMPHOMA 6 PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: BCL-6,B-CELL LYMPHOMA 5 PROTEIN,BCL-5,PROTEIN LAZ-3,ZINC COMPND 5 FINGER AND BTB DOMAIN-CONTAINING PROTEIN 27,ZINC FINGER PROTEIN 51; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCL6, BCL5, LAZ3, ZBTB27, ZNF51; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, PROTEIN-PROTEIN INTERACTION, PROTEIN BINDING, PROTEIN KEYWDS 2 BINDING-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR B.LINHARES,H.CHENG,T.CIERPICKI,F.XUE REVDAT 3 04-OCT-23 6C3L 1 REMARK REVDAT 2 31-JUL-19 6C3L 1 JRNL REVDAT 1 16-JAN-19 6C3L 0 JRNL AUTH H.CHENG,B.M.LINHARES,W.YU,M.G.CARDENAS,Y.AI,W.JIANG, JRNL AUTH 2 A.WINKLER,S.COHEN,A.MELNICK,A.MACKERELL JR.,T.CIERPICKI, JRNL AUTH 3 F.XUE JRNL TITL IDENTIFICATION OF THIOUREA-BASED INHIBITORS OF THE B-CELL JRNL TITL 2 LYMPHOMA 6 BTB DOMAIN VIA NMR-BASED FRAGMENT SCREENING AND JRNL TITL 3 COMPUTER-AIDED DRUG DESIGN. JRNL REF J.MED.CHEM. V. 61 7573 2018 JRNL REFN ISSN 0022-2623 JRNL PMID 29969259 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00040 REMARK 2 REMARK 2 RESOLUTION. 1.46 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.46 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.02 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.003 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 38461 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.870 REMARK 3 FREE R VALUE TEST SET COUNT : 1873 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 30.0309 - 3.4335 0.95 2806 131 0.1868 0.2042 REMARK 3 2 3.4335 - 2.7259 0.97 2872 151 0.1930 0.2094 REMARK 3 3 2.7259 - 2.3815 0.98 2884 115 0.2012 0.2867 REMARK 3 4 2.3815 - 2.1638 0.97 2837 163 0.1948 0.2316 REMARK 3 5 2.1638 - 2.0087 0.97 2867 157 0.2066 0.2729 REMARK 3 6 2.0087 - 1.8903 0.96 2806 131 0.2023 0.2351 REMARK 3 7 1.8903 - 1.7957 0.96 2828 124 0.2151 0.2521 REMARK 3 8 1.7957 - 1.7175 0.97 2793 157 0.2138 0.2895 REMARK 3 9 1.7175 - 1.6514 0.95 2856 111 0.2144 0.2554 REMARK 3 10 1.6514 - 1.5944 0.95 2823 119 0.2119 0.2268 REMARK 3 11 1.5944 - 1.5446 0.96 2820 130 0.2290 0.2363 REMARK 3 12 1.5446 - 1.5004 0.94 2733 175 0.2368 0.2765 REMARK 3 13 1.5004 - 1.4609 0.93 2663 209 0.2552 0.2701 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.149 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.361 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.04 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2102 REMARK 3 ANGLE : 0.588 2857 REMARK 3 CHIRALITY : 0.064 333 REMARK 3 PLANARITY : 0.003 352 REMARK 3 DIHEDRAL : 16.750 835 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN A AND RESSEQ 5:128) REMARK 3 ORIGIN FOR THE GROUP (A): -30.1782 1.4480 -1.5893 REMARK 3 T TENSOR REMARK 3 T11: 0.1686 T22: 0.1663 REMARK 3 T33: 0.1388 T12: 0.0771 REMARK 3 T13: 0.0127 T23: -0.0090 REMARK 3 L TENSOR REMARK 3 L11: 1.0499 L22: 2.2904 REMARK 3 L33: 3.5338 L12: -0.0514 REMARK 3 L13: 0.5463 L23: -0.9104 REMARK 3 S TENSOR REMARK 3 S11: -0.2002 S12: -0.1558 S13: 0.0651 REMARK 3 S21: 0.3552 S22: 0.1443 S23: 0.0584 REMARK 3 S31: -0.4488 S32: -0.3294 S33: 0.0572 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: (CHAIN B AND RESSEQ 5:127) REMARK 3 ORIGIN FOR THE GROUP (A): -18.9944 1.2416 -21.9504 REMARK 3 T TENSOR REMARK 3 T11: 0.1878 T22: 0.1790 REMARK 3 T33: 0.1385 T12: -0.1014 REMARK 3 T13: 0.0237 T23: 0.0245 REMARK 3 L TENSOR REMARK 3 L11: 1.1712 L22: 2.0578 REMARK 3 L33: 3.7972 L12: -0.1286 REMARK 3 L13: 0.6695 L23: 0.9108 REMARK 3 S TENSOR REMARK 3 S11: -0.2062 S12: 0.1786 S13: 0.0500 REMARK 3 S21: -0.3760 S22: 0.1477 S23: -0.0428 REMARK 3 S31: -0.4184 S32: 0.3350 S33: 0.0726 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6C3L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JAN-18. REMARK 100 THE DEPOSITION ID IS D_1000232011. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-OCT-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97857 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38467 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.460 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.46 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.51 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1R29 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE PH 4.5, 27% (W/V) REMARK 280 PEG-3,350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 PRO A 4 REMARK 465 GLU A 129 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 PRO B 4 REMARK 465 GLU B 129 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 6 CG OD1 OD2 REMARK 470 SER A 39 OG REMARK 470 ASP A 63 CG OD1 OD2 REMARK 470 GLN A 64 CG CD OE1 NE2 REMARK 470 ARG A 122 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 6 CG OD1 OD2 REMARK 470 ARG B 13 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 63 OD1 OD2 REMARK 470 LEU B 65 CG CD1 CD2 REMARK 470 ARG B 94 CZ NH1 NH2 REMARK 470 HIS B 116 CG ND1 CD2 CE1 NE2 REMARK 470 SER B 128 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 39 -119.48 57.99 REMARK 500 SER B 39 -119.00 60.03 REMARK 500 MET B 114 77.17 -115.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 451 DISTANCE = 5.97 ANGSTROMS REMARK 525 HOH A 452 DISTANCE = 6.21 ANGSTROMS REMARK 525 HOH A 453 DISTANCE = 6.33 ANGSTROMS REMARK 525 HOH A 454 DISTANCE = 6.81 ANGSTROMS REMARK 525 HOH A 455 DISTANCE = 8.54 ANGSTROMS REMARK 525 HOH A 456 DISTANCE = 9.28 ANGSTROMS REMARK 525 HOH B 429 DISTANCE = 6.79 ANGSTROMS REMARK 525 HOH B 430 DISTANCE = 7.36 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EGP A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EGP B 201 DBREF 6C3L A 5 129 UNP P41182 BCL6_HUMAN 5 129 DBREF 6C3L B 5 129 UNP P41182 BCL6_HUMAN 5 129 SEQADV 6C3L GLY A -1 UNP P41182 EXPRESSION TAG SEQADV 6C3L SER A 0 UNP P41182 EXPRESSION TAG SEQADV 6C3L MET A 1 UNP P41182 EXPRESSION TAG SEQADV 6C3L ALA A 2 UNP P41182 EXPRESSION TAG SEQADV 6C3L SER A 3 UNP P41182 EXPRESSION TAG SEQADV 6C3L PRO A 4 UNP P41182 EXPRESSION TAG SEQADV 6C3L GLN A 8 UNP P41182 CYS 8 ENGINEERED MUTATION SEQADV 6C3L ARG A 67 UNP P41182 CYS 67 ENGINEERED MUTATION SEQADV 6C3L ASN A 84 UNP P41182 CYS 84 ENGINEERED MUTATION SEQADV 6C3L VAL A 99 UNP P41182 GLU 99 ENGINEERED MUTATION SEQADV 6C3L GLY B -1 UNP P41182 EXPRESSION TAG SEQADV 6C3L SER B 0 UNP P41182 EXPRESSION TAG SEQADV 6C3L MET B 1 UNP P41182 EXPRESSION TAG SEQADV 6C3L ALA B 2 UNP P41182 EXPRESSION TAG SEQADV 6C3L SER B 3 UNP P41182 EXPRESSION TAG SEQADV 6C3L PRO B 4 UNP P41182 EXPRESSION TAG SEQADV 6C3L GLN B 8 UNP P41182 CYS 8 ENGINEERED MUTATION SEQADV 6C3L ARG B 67 UNP P41182 CYS 67 ENGINEERED MUTATION SEQADV 6C3L ASN B 84 UNP P41182 CYS 84 ENGINEERED MUTATION SEQADV 6C3L VAL B 99 UNP P41182 GLU 99 ENGINEERED MUTATION SEQRES 1 A 131 GLY SER MET ALA SER PRO ALA ASP SER GLN ILE GLN PHE SEQRES 2 A 131 THR ARG HIS ALA SER ASP VAL LEU LEU ASN LEU ASN ARG SEQRES 3 A 131 LEU ARG SER ARG ASP ILE LEU THR ASP VAL VAL ILE VAL SEQRES 4 A 131 VAL SER ARG GLU GLN PHE ARG ALA HIS LYS THR VAL LEU SEQRES 5 A 131 MET ALA CYS SER GLY LEU PHE TYR SER ILE PHE THR ASP SEQRES 6 A 131 GLN LEU LYS ARG ASN LEU SER VAL ILE ASN LEU ASP PRO SEQRES 7 A 131 GLU ILE ASN PRO GLU GLY PHE ASN ILE LEU LEU ASP PHE SEQRES 8 A 131 MET TYR THR SER ARG LEU ASN LEU ARG VAL GLY ASN ILE SEQRES 9 A 131 MET ALA VAL MET ALA THR ALA MET TYR LEU GLN MET GLU SEQRES 10 A 131 HIS VAL VAL ASP THR CYS ARG LYS PHE ILE LYS ALA SER SEQRES 11 A 131 GLU SEQRES 1 B 131 GLY SER MET ALA SER PRO ALA ASP SER GLN ILE GLN PHE SEQRES 2 B 131 THR ARG HIS ALA SER ASP VAL LEU LEU ASN LEU ASN ARG SEQRES 3 B 131 LEU ARG SER ARG ASP ILE LEU THR ASP VAL VAL ILE VAL SEQRES 4 B 131 VAL SER ARG GLU GLN PHE ARG ALA HIS LYS THR VAL LEU SEQRES 5 B 131 MET ALA CYS SER GLY LEU PHE TYR SER ILE PHE THR ASP SEQRES 6 B 131 GLN LEU LYS ARG ASN LEU SER VAL ILE ASN LEU ASP PRO SEQRES 7 B 131 GLU ILE ASN PRO GLU GLY PHE ASN ILE LEU LEU ASP PHE SEQRES 8 B 131 MET TYR THR SER ARG LEU ASN LEU ARG VAL GLY ASN ILE SEQRES 9 B 131 MET ALA VAL MET ALA THR ALA MET TYR LEU GLN MET GLU SEQRES 10 B 131 HIS VAL VAL ASP THR CYS ARG LYS PHE ILE LYS ALA SER SEQRES 11 B 131 GLU HET EGP A 201 41 HET EGP B 201 41 HETNAM EGP N-[2-(1H-INDOL-3-YL)ETHYL]-N'-{3-[(4-METHYLPIPERAZIN-1- HETNAM 2 EGP YL)METHYL]-1-[2-(MORPHOLIN-4-YL)-2-OXOETHYL]-1H-INDOL- HETNAM 3 EGP 6-YL}THIOUREA FORMUL 3 EGP 2(C31 H39 N7 O2 S) FORMUL 5 HOH *286(H2 O) HELIX 1 AA1 ARG A 13 ARG A 28 1 16 HELIX 2 AA2 HIS A 46 SER A 54 1 9 HELIX 3 AA3 SER A 54 ASP A 63 1 10 HELIX 4 AA4 ASN A 79 SER A 93 1 15 HELIX 5 AA5 ASN A 101 GLN A 113 1 13 HELIX 6 AA6 MET A 114 SER A 128 1 15 HELIX 7 AA7 ARG B 13 ARG B 28 1 16 HELIX 8 AA8 HIS B 46 SER B 54 1 9 HELIX 9 AA9 SER B 54 ASP B 63 1 10 HELIX 10 AB1 ASN B 79 SER B 93 1 15 HELIX 11 AB2 ASN B 101 LEU B 112 1 12 HELIX 12 AB3 MET B 114 ALA B 127 1 14 SHEET 1 AA1 2 ILE A 9 GLN A 10 0 SHEET 2 AA1 2 ARG B 94 LEU B 95 -1 O LEU B 95 N ILE A 9 SHEET 1 AA2 3 GLU A 41 ALA A 45 0 SHEET 2 AA2 3 VAL A 34 VAL A 38 -1 N ILE A 36 O PHE A 43 SHEET 3 AA2 3 VAL A 71 ASN A 73 1 O ILE A 72 N VAL A 37 SHEET 1 AA3 2 ARG A 94 LEU A 95 0 SHEET 2 AA3 2 ILE B 9 GLN B 10 -1 O ILE B 9 N LEU A 95 SHEET 1 AA4 3 GLU B 41 ALA B 45 0 SHEET 2 AA4 3 VAL B 34 VAL B 38 -1 N ILE B 36 O PHE B 43 SHEET 3 AA4 3 VAL B 71 ASN B 73 1 O ILE B 72 N VAL B 37 SITE 1 AC1 17 GLU A 41 MET A 51 ALA A 52 CYS A 53 SITE 2 AC1 17 GLY A 55 TYR A 58 GLU A 81 ASN A 84 SITE 3 AC1 17 GLY A 100 GLN A 113 GLU A 115 HIS A 116 SITE 4 AC1 17 HOH A 305 HOH A 338 ASP B 17 ASN B 21 SITE 5 AC1 17 ARG B 28 SITE 1 AC2 16 ASP A 17 ASN A 21 ARG A 28 HOH A 330 SITE 2 AC2 16 GLU B 41 MET B 51 ALA B 52 CYS B 53 SITE 3 AC2 16 GLY B 55 TYR B 58 GLU B 81 ASN B 84 SITE 4 AC2 16 GLY B 100 GLN B 113 GLU B 115 HOH B 355 CRYST1 30.930 39.589 55.182 83.75 73.85 66.96 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.032331 -0.013749 -0.009365 0.00000 SCALE2 0.000000 0.027449 0.000002 0.00000 SCALE3 0.000000 0.000000 0.018867 0.00000